New From Your Syphilis Authority
Pending FDA Clearance
Introducing the next evolution in syphilis testing which complies with the CDC recommended traditional algorithm for nontreponemal syphilis screening.1 Laboratories can now automate nontreponemal testing and drive significant operational efficiencies while minimizing false-positive results.
The USA made ASI Evolution is a fully automated syphilis analyzer. Laboratories will benefit from ASI Evolution substantially lower capital expenditure, and lower cost per test. The user friendly, system is capable of performing more than 190 tests per hour in a full walk-away platform. The analyzer does not require custom designed and expensive consumables. This Value Proposition will allow laboratories using the ASI Evolution to enjoy important savings in both labor and efficiency.
1. MMWR, Vol. 60, #5, Feb. 11, 2011
Evaluation of the ASI Evolution™ Automated Syphilis Analyzer
A total of 3217 specimens were evaluated to determine reactivity. Of the 3217 specimens, 1093 were reactive and 2124 specimens were nonreactive visually. The ASI Evolution identified 1080 of the 1093 reactive specimens as reactive and 2121 of the 2124 nonreactive specimens as nonreactive. A sensitivity of 98.8% and a specificity of 99.8% were determined.
ASI Evolution Digital Results
The reactive samples ranged in reactivity from minimal 1:1 titers to 1:64 titers.
The Nontreponemal Advantage
Courtesy of Centers for Disease Control and Prevention
The Arlington Scientific Advantage
ASI Evolution Video
The Evolution shown in the video is a prototype for demonstration purposes only. Actual model shown above.
Request more product Information